Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
APH1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLPTM1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PET117 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARID1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP8B5P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ING1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM86A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF436 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM50A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF664-FAM101A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SENP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on